ERBB2 and gastric cancer: Heregulin can activate HER3-promoted signaling pathways via HER1/HER3 or HER2/HER3 heterodimers [23]; however, it has not been elucidated so far which of these heterodimers mediate these pro-survival effects in MET addicted gastric cancer cells.